Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126756 · ClinicalTrials.gov registry record · NA
LASIK iDesign vs SMILE
A NA study of Myopia and Astigmatism, sponsored by 59th Medical Wing.
- Active
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT07126756: Active NA study of Myopia and Astigmatism, sponsored by 59th Medical Wing.
NCT07126756 is a NA study of Myopia and Astigmatism that is active but no longer recruiting, run by 59th Medical Wing. The registered enrollment target is 57 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07126756, a NA study of Myopia and Astigmatism, is active but no longer recruiting, sponsored by 59th Medical Wing.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will compare the 6-month visual outcomes (i.e., visual acuity, contract sensitivity, higher order aberrations), quality of vision (i.e., double vision, glare, starburst, halos, etc.) and dry eye symptoms of patients undergoing contralateral LASIK using iDesign and SMILE surgery.
Primary Outcome
Post-operative uncorrected visual acuity of 20/16 or better measure using the ETDRS chart reported as percentage of subjects; unit = percentage eyes with Uncorrected Visual Acuity
Conditions Studied
Interventions
- DEVICE STAR S4 IR Excimer Laser System
- DEVICE VisuMax 400 Surgical Laser
Study Locations (1)
Texas
- Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center - Lackland Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT07126756 still lists
NCT07126756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which STAR S4 IR Excimer Laser System is the first listed.
NCT07126756 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07126756 about?
NCT07126756 is a clinical study titled "LASIK iDesign vs SMILE". The study will compare the 6-month visual outcomes (i.e., visual acuity, contract sensitivity, higher order aberrations), quality of vision (i.e., double vision, glare, starburst, halos, etc.) and dry eye symptoms of patients undergoing contralateral LASIK using iDesign and SMILE surgery.
What is the current status of trial NCT07126756?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2024-06-10. Estimated completion is 2026-01-31.
What conditions does trial NCT07126756 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT07126756?
The interventions under investigation include: STAR S4 IR Excimer Laser System (DEVICE), VisuMax 400 Surgical Laser (DEVICE).
Who is sponsoring clinical trial NCT07126756?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07126756 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07126756's enrollment target sits among peer trials
57 62nd of 90 higher than 29 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI